المؤلفون: Ruperto N, Brunner HI, Synoverska O, Ting TV, Mendoza CA, Spindler A, Vyzhga Y, Marzan K, Grebenkina L, Tirosh I, Imundo L, Jerath R, Kingsbury DJ, Sozeri B, Vora SS, Prahalad S, Zholobova E, Butbul Aviel Y, Chasnyk V, Lerman M, Nanda K, Schmeling H, Tory H, Uziel Y, Viola DO, Posner HB, Kanik KS, Wouters A, Chang C, Zhang R, Lazariciu I, Hsu MA, Suehiro RM, Martini A, Lovell DJ

المساهمون: Ruperto, N, Brunner, H, Synoverska, O, Ting, T, Mendoza, C, Spindler, A, Vyzhga, Y, Marzan, K, Grebenkina, L, Tirosh, I, Imundo, L, Jerath, R, Kingsbury, D, Sozeri, B, Vora, S, Prahalad, S, Zholobova, E, Butbul Aviel, Y, Chasnyk, V, Lerman, M, Nanda, K, Schmeling, H, Tory, H, Uziel, Y, Viola, D, Posner, H, Kanik, K, Wouters, A, Chang, C, Zhang, R, Lazariciu, I, Hsu, M, Suehiro, R, Martini, A, Lovell, D

مصطلحات موضوعية: Administration, Oral, Adolescent, Arthritis, Juvenile, Child, Preschool, Human, Janus Kinase Inhibitor, Piperidine, Pyrimidine, Treatment Outcome

وصف الملف: STAMPA

Relation: info:eu-repo/semantics/altIdentifier/pmid/34767764; info:eu-repo/semantics/altIdentifier/wos/WOS:000722897200031; volume:398; issue:10315; firstpage:1984; lastpage:1996; numberofpages:13; journal:THE LANCET; https://hdl.handle.net/10281/524033

الاتاحة: https://hdl.handle.net/10281/524033
https://doi.org/10.1016/S0140-6736(21)01255-1